| Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status PD Harvey, M Strassnig World Psychiatry 11 (2), 73-79, 2012 | 345 | 2012 |
| Nutritional assessment of patients with schizophrenia: a preliminary study M Strassnig, JS Brar, R Ganguli Schizophrenia Bulletin 29 (2), 393-397, 2003 | 228 | 2003 |
| Determinants of different aspects of everyday outcome in schizophrenia: the roles of negative symptoms, cognition, and functional capacity MT Strassnig, T Raykov, C O'Gorman, CR Bowie, S Sabbag, D Durand, ... Schizophrenia research 165 (1), 76-82, 2015 | 211 | 2015 |
| Body mass index and quality of life in community-dwelling patients with schizophrenia M Strassnig, JS Brar, R Ganguli Schizophrenia research 62 (1-2), 73-76, 2003 | 181 | 2003 |
| Risperidone plasma levels, clinical response and side–effects M Riedel, MJ Schwarz, M Strassnig, I Spellmann, A Müller–Arends, ... European archives of psychiatry and clinical neuroscience 255, 261-268, 2005 | 167 | 2005 |
| Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis M Strassnig, J Miewald, M Keshavan, R Ganguli Schizophrenia research 93 (1-3), 90-98, 2007 | 163 | 2007 |
| Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia M Strassnig, JS Brar, R Ganguli Schizophrenia research 126 (1-3), 103-109, 2011 | 116 | 2011 |
| Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment PD Harvey, MT Strassnig, J Silberstein Journal of Experimental Psychopathology 10 (3), 2043808719865693, 2019 | 114 | 2019 |
| About a peculiar disease of the cerebral cortex: Alzheimer's original case revisited M Strassnig, M Ganguli Psychiatry (Edgmont) 2 (9), 30, 2005 | 114 | 2005 |
| Quetiapine in the treatment of schizophrenia and related disorders M Riedel, N Müller, M Strassnig, I Spellmann, E Severus, HJ Möller Neuropsychiatric disease and treatment 3 (2), 219-235, 2007 | 113 | 2007 |
| Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies D Durand, M Strassnig, S Sabbag, F Gould, EW Twamley, TL Patterson, ... European Neuropsychopharmacology 25 (2), 185-191, 2015 | 100 | 2015 |
| Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia CA Depp, M Strassnig, BT Mausbach, CR Bowie, P Wolyniec, ... Bipolar disorders 16 (4), 422-431, 2014 | 93 | 2014 |
| Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia M Strassnig, JS Brar, R Ganguli Schizophrenia research 86 (1-3), 269-275, 2006 | 93 | 2006 |
| Decreased T cellular immune response in schizophrenic patients M Riedel, I Spellmann, MJ Schwarz, M Strassnig, C Sikorski, HJ Möller, ... Journal of psychiatric research 41 (1-2), 3-7, 2007 | 90 | 2007 |
| Physical performance and disability in schizophrenia M Strassnig, J Signorile, C Gonzalez, PD Harvey Schizophrenia Research: Cognition 1 (2), 112-121, 2014 | 83 | 2014 |
| Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia? M Strassnig, C Bowie, AE Pinkham, D Penn, EW Twamley, TL Patterson, ... Journal of psychiatric research 104, 124-129, 2018 | 82 | 2018 |
| Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms M Riedel, I Spellmann, M Strassnig, A Douhet, S Dehning, ... European archives of psychiatry and clinical neuroscience 257, 360-370, 2007 | 82 | 2007 |
| Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms M Riedel, N Müller, M Strassnig, I Spellmann, RR Engel, R Musil, ... European archives of psychiatry and clinical neuroscience 255, 432-437, 2005 | 79 | 2005 |
| How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? M Riedel, M Strassnig, N Müller, P Zwack, HJ Möller European archives of psychiatry and clinical neuroscience 255, 143-148, 2005 | 78 | 2005 |
| Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia M Strassnig, JS Brar, R Ganguli Schizophrenia research 76 (2-3), 343-351, 2005 | 71 | 2005 |
Philip D. HarveyUniversity of MiamiVerified email at miami.edu
